RBMS3 is a novel candidate gene for suppressing tumors as in esophageal squamous cell carcinoma (ESCC) [23], breast cancer [24], nasopharyngeal cancer (NPC) [25], and lung squamous cell carcinoma (LSCC) [26]. This evidence concerns the gene RBMS3 and breast cancer.